Hydrosalpinx – salpingostomy, salpingectomy or tubal occlusion

Publication date: Available online 29 January 2019Source: Best Practice & Research Clinical Obstetrics & GynaecologyAuthor(s): Ka Ying Bonnie Ng, Ying CheongAbstractTubal factors account for around 25% of cases of infertility and the most severe manifestation of tubal disease is hydrosalpinx, accounting for 10-30% of tubal diseases. Hydrosalpinx is a distension or dilatation of the Fallopian tube in the presence of a distal tubal occlusion, and the most common cause is pelvic inflammatory disease. Women with hydrosalpinges have lower implantation and pregnancy rates in assisted reproductive technology (ART), due to a combination of mechanical and chemical factors thought to disrupt the endometrial environment. Current guidance is removal the tube by salpingectomy (preferably laparoscopically) prior to IVF treatment. Salpingostomy, or distal tubal plastic surgery in the management of hydrosalpinx is an alternative for women desiring natural conception, although ectopic pregnancy rates as high as 10% have been reported. Proximal tubal occlusion with Essure ® devices placed hysteroscopically can be considered especially in cases of distorted pelvic anatomy or pelvic adhesions making abdominal surgery complex. However, lower clinical pregnancy and live birth rates have been reported with the use of these devices prior to IVF. In the review, we discuss salpingostomy, salpingectomy and hysteroscopic tubal occlusion as possible management options for the reproductive women with hyd...

Source: Best Practice and Research Clinical Obstetrics and Gynaecology - January 30, 2019 Category: OBGYN Source Type: research